International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Psoriasis News

THE LATEST FROM IPC, INDUSTRY, AND NEWS

Results

IPC appoints 5 new councilors

They join an esteemed group of IPC psoriasis experts working to better patient care We are pleased to introduce our newest IPC Councilors, including for the first time, dermatologists from Bangladesh and Guatemala. Councilors are selected based on overall reputation in the dermatology community, involvement in psoriasis research, and demonstrated interest in psoriasis care and treatment. Meet our councilors.

Read More

Declaración sobre el brote de coronavirus

Declaración del IPC sobre COVID y psoriasis La pandemia de SARS-CoV-2 continúa siendo una preocupación sanitaria de gravedad a nivel global. Desde que el Consejo Internacional de Psoriasis (IPC) publicó su declaración sobre COVID-19 el 11 de marzo, el coronavirus continúa propagándose rápidamente y actualmente constituye un peligro sanitario preponderante en todos los países de ingresos económicos altos, medios y bajos.

Read More
IPC logo

IPC Statement on COVID-19 and Psoriasis

The SARS-CoV-2 pandemic continues to have a considerable impact on the provision of appropriate care to people with psoriasis. In an updated statement, IPC advises physicians and other healthcare practitioners to take into account these important issues that relate to the management of psoriasis during the pandemic.

Read More
image of computer with words expert commentary

Commentary: Psoriasis treat to target: defining outcomes in psoriasis

In moderate to severe psoriasis, there has been a long-lasting tradition to define outcome as a relative change from baseline PASI, with the classical PASI 75 being more recently replaced by PASI 90 or 100. However, this concept is dated, mainly due to the impressive development of anti-interleukin therapies and an increasing interest in real-world evidence.

Read More
image of computer with words expert commentary

Commentary: Dermatologists and SARS – CoV – 2: the impact of the pandemic on daily practice

Paolo Gisondi et al., summarize issues faced by many dermatologists during the unprecedented lockdown period in Spring 2020 due to the COVID-19 pandemic. Issues like the sudden cancellation of face-to-face consultations, and the mandatory introduction of telemedicine (after months of a rather optional exercise with this type of caregiving), needed an entrepreneurial approach to manage.

Read More
image of computer with words expert commentary

Mark Lebwohl COVID-19

Commentary from IPC Councilor Mark Lebwohl, MD, on a case series in NEJM on COVID-19 in immune-mediated inflammatory diseases.

Read More

Categories

New Resources

Focus on Psoriasis: A Report from the 2022 Society for Investigative Dermatology (SID) Annual Meeting

Un Enfoque en Psoriasis – Un Reporte de el Congreso RADLA 2022

Introduction to IPC & Real-world Data in Psoriasis

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.